Translational biology of osteosarcoma

Kansara, Maya, Teng, Michele W., Smyth, Mark J., Thomas, David M.·2014·Nature Reviews Cancer

DOI 10.1038/nrc3838

Cited by (1,000)

Items 801–900 of 1,000

Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment
Yilong Dong, Lingshuang Wang, Hui Zhang, Menghuan Li, Zhong Yuan Luo, Yan Hu, Chun-Yuan Cai · 2025 · Advanced Science
Decoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells
Haitian Wang, Tongtong Zhu, Kunpeng Yang, Chenkai Xu, Zhaoyi Zhang, Guangyao Liu, Hongge Ren · 2025 · Frontiers in Oncology
Research trends and hotspots in the immune microenvironment related to osteosarcoma and tumor cell aging: a bibliometric and visualization study
Wenlong Zhang, Zhuce Shao · 2023 · Frontiers in Endocrinology
Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
Hefen Chen, Zhujun Gong, Hong Wei Zhou, Yong Kwon Han · 2024 · Drug Development Research
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma
Sabeena Giri, Kevin J H Allen, Chandra Bose Prabaharan, Jonathan Bonet Ramírez, L. Fiore, Maruti Uppalapati, Ekaterina Dadachova · 2024 · Nuclear Medicine and Biology
Oral microbiota distinguishes patients with osteosarcoma from healthy controls
Yu Chen, Chao Li, Xin Wang, Chun Lei Zhang, Zhi Gang Ren, Zhong Quan Wang · 2024 · Frontiers in Cellular and Infection Microbiology
LncRNA HOXA-AS3 promotes cell proliferation and invasion via targeting miR-218-5p/FOXP1 axis in osteosarcoma
Rong Li, Pingbo Chen, Yubo Zhou, Yi Lang, Changhui Zhou, Jingqin Ren, Adilijiang Maimaitiyimin, Zhen Chen, Chengqing Liu, Abasi mainike et al. · 2024 · Scientific Reports
Controllable All-in-One Biomimetic Hollow Nanoscaffold Initiating Pyroptosis-Mediated Antiosteosarcoma Targeted Therapy and Bone Defect Repair
Qiming Ma, Shenglin Xu, Qian Wang, Yukang Que, Peng He, Rui Yang, Hao Wang, Ziheng Wu, Longze Xiao, Xingshi Yuan et al. · 2024 · ACS Applied Materials & Interfaces
Natural lung-tropic TH9 cells: a sharp weapon for established lung metastases
Tao Chen, Chenxiao Qiao, Eloy Yinwang, Shengdong Wang, Xuehuan Wen, Yixuan Feng, Xiangang Jin, Shu-Ming Li, Yucheng Xue, Hao Zhou et al. · 2024 · Journal for ImmunoTherapy of Cancer
Epigenetically driven network cooperativity: meta-analysis in multi-drug resistant osteosarcoma
Antonio Mora, Monia Taranta, Nazar Zaki, Caterina Cinti, Enrico Capobianco · 2015 · Journal of Complex Networks
Allelic Expression Imbalance Analysis Identified YAP1 Amplification in p53- Dependent Osteosarcoma
Guanglin Niu, Agnieszka Bak, Melanie Nusselt, Yue Zhang, Hubert Pausch, Tatiana Flisikowska, Angelika Schnieke, Krzysztof Flisikowski · 2021 · Cancers
Identification of Gene as Predictive Biomarkers for the Occurrence and Recurrence of Osteosarcoma
Yuanguo Luo, Bo Lv, Shaokang He, Kai Zou, Kezhi Hu · 2021 · International Journal of General Medicine
Circ_0016347 modulates proliferation, migration, invasion, cell cycle, and apoptosis of osteosarcoma cells via the miR-661/IL6R axis
Yan Liu, Jianjun Yuan, Quan Zhang, Zhishuai Ren, Guang Li, Rong Tian · 2022 · Autoimmunity
Correlation between Patient‐Derived Xenograft Modeling and Prognosis in Osteosarcoma
Mengxiong Sun, Zongyi Wang, Wei Yan Sun, Ming Chen, Xiaojun Ma, Jiakang Shen, Zeze Fu, Dongqing Zuo, Gangyang Wang, Hongsheng Wang et al. · 2022 · Orthopaedic Surgery
Propofol inhibits the malignant development of osteosarcoma U2OS cells via AMPK/FΟΧO1‑mediated autophagy
Lina Dai, Shimei Li, Xi Li, Bo Jiang · 2022 · Oncology Letters
Nucleic acid therapy in pediatric cancer
Yongshu Li, Bihui Huang, Zhichao Xue, Yunhua Gao, Zhenjian Zhuo · 2022 · Pharmacological Research
Comparison of Selected Non-Coding RNAs and Gene Expression Profiles between Common Osteosarcoma Cell Lines
Mateusz Sikora, Katarzyna Krajewska, Klaudia A. Marcinkowska, Anna Raciborska, Rafal Jakub Wiglusz, Agnieszka Śmieszek · 2022 · Cancers
T52 attenuates oncogenic STAT3 signaling and suppresses osteosarcoma
Liru Tian, Chuan Li, Limin Xiang, Jia Zeng, Shuqing Chen, Weimin Guo, Shulin Chen, Yihai Wang, Xiangjiu He, Peiqiang Su et al. · 2023 · Phytomedicine
A Binary Survivability Prediction Classification Model towards Understanding of Osteosarcoma Prognosis
Saravanan Muthaiyah, Vivek Ajit Singh, Thein Oak Kyaw Zaw, Kalaiarasi Sonai Muthu Anbananthen, Byeonghwa Park, Myung‐Joon Kim · 2023 · Emerging Science Journal
Involvement of α5 integrin in survivin-mediated osteosarcoma metastasis
Xiao-Zhou Liu, Chengjun Li, Sujia Wu, Xin Shi, Jian-Ning Zhao · 2016 · Asian Pacific Journal of Tropical Medicine
Secretory defects in pediatric osteosarcoma result from downregulation of selective COPII coatomer proteins
Rachael K. Wood, Ashley R. Flory, Melissa J. Mann, Lindsay Jones Talbot, Linda M. Hendershot · 2022 · iScience
Development of a Risk Score Model for Osteosarcoma Based on DNA Methylation-Driven Differentially Expressed Genes
Yuxiang Kang, Guowang Li, Guohua Wang, Zhenxin Huo, Xiangling Feng, Lilong Du, Yongjin Li, Qiang Yang, Xinlong Ma, Bingbing Yu et al. · 2022 · Journal of Oncology
Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation
Fu-Li Xie, Yan Wang, Jianwei Zhu, Hui-Hua Xu, Qi-Feng Guo, Yong Wu, Sihong Liu · 2022 · Journal of Inorganic Biochemistry
Heparanase: A Potential Therapeutic Target in Sarcomas
Giuliana Cassinelli, Cinzia Lanzi · 2020 · Advances in experimental medicine and biology
Afatinib is active in osteosarcoma in osteosarcoma cell lines
Marlid Cruz‐Ramos, Yessica Eduviges Zamudio-Cuevas, Daniel Medina-Luna, Karina Martínez‐Flores, Gabriela Angélica Martínez‐Nava, Javier Fernández‐Torres, Alberto Gabriel López-Reyes, Flavio Solca · 2020 · Journal of Cancer Research and Clinical Oncology
Retraction: A005, a novel inhibitor of phosphatidylinositol 3-kinase/mammalian target of rapamycin, prevents osteosarcoma-induced osteolysis
Zhen Lian, Jinsong Han, Lin Chong Huang, Chengming Wei, Yongyong Fan, Jiake Xu, Mengyu Zhou, Haotian Feng, Qian Liu, Lingzi Chen et al. · 2018 · Carcinogenesis · Retracted
Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model
Laura Ben Olivo, Pricilla de Oliveira Henz, Sophia Wermann, Bruna Bernar Dias, Gabriel Osorio Porto, Amanda Valle Pinhatti, Manoela Domingues Martins, Lauro José Gregianin, Teresa Dalla Costa, Bibiana Verlindo de Araújo · 2024 · Pharmaceutics
Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment
Zewei Zhang, Fang He, Wenqu Li, Beibei Liu, Cheng Dan Deng, Xiaojuan Qin · 2025 · Journal of Functional Biomaterials
The paradoxical role of stem cells in osteosarcoma: from pathogenesis to therapeutic breakthroughs
Zhengbing Su, Xiang Fang, Hong Quan Duan · 2025 · Frontiers in Oncology
Rab27b-mediated CAFs derived exosomal miR-22-3p suppresses ferroptosis and promotes cisplatin resistance in osteosarcoma
Wenyuan Duan, Xiaoying Niu, Yunsong Liu, Wen Tian · 2025 · Cellular Signalling
Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment
Lei He, Pamela Habibović, Sabine van Rijt · 2025 · Journal of Controlled Release
Radiomics for predicting sensitivity to neoadjuvant chemotherapy in osteosarcoma: current status and advances
Panhong Zhang, Weitao Yao, Zhehuang Li, Yichao Fan, Xinhui Du, Bangmin Wang, Fan Zhang, Jingyu Hou, Qilong Su · 2025 · Oncology Reviews
pH/ROS-responsive magnesium scaffold functionalized via hydrazone bonds for localized postoperative bone tumor therapy
Yanfeng Ding, Xing Fen, Song Chen, Yiqing Zhang, Qingjiang Pang · 2025 · Colloids and Surfaces B Biointerfaces
Nanodynamic therapies for osteosarcoma: Recent advances and future perspectives
Yujia Xin, Jialing Yao, Wenyan Qiao, Wan Liu, Xiufu Hua, Xiaoyan Zheng, Junfeng Hui, Daidi Fan · 2025 · Chemical Engineering Journal
C/ebpα represses the oncogenic Runx3–Myc axis in p53-deficient osteosarcoma development
Keisuke Omori, Shohei Otani, Yuki Date, Tomoya Ueno, Tomoko Ito, Masahiro Umeda, Kosei Ito · 2023 · Oncogene
Bulk and single-cell sequencing identified a prognostic model based on the macrophage and lipid metabolism related signatures for osteosarcoma patients
Zili Lin, Ziyi Wu, Wei Luo · 2024 · Heliyon
USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches
Qiao Zhang, Jinwei Zhu, Jian Xie, Yurong Gu, Lu Chen · 2024 · PeerJ
System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy
Zhouwei Wu, Jiapei Yu, Tao Han, Yiting Tu, Fang Su, Shi Li, Yixing Huang · 2024 · BMC Musculoskeletal Disorders
Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
Liujing Qu, Xin Yu, Jieni Feng, Xiaolei Ren, Zuming Li, Xueru Chen, Guangyan Miao, Jiankun Chen, Chengming Sun, Yue Lu · 2024 · Frontiers in Oncology
Identification of UNC5B as a novel aggressive biomarker for osteosarcoma based on basement membrane genes
Ruilin Pan, Yiming Zhang, Yanmei Cheng, Zelin Wu, Jin Liu, Zihang Chen, Jinghao Wang, Xiaofang Zhang, Huajun Wang, Shanshan Feng et al. · 2024 · Gene
Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells
Bo Li, Qianhui Zhao, Hanyu Yang, Xueyuying Wang, Zhijun Zhang, Yanling Gong, Wan Xu · 2024 · AAPS PharmSciTech
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial
Abha A. Gupta, Anna V. Tinker, D. Jonker, R. Jamal, Hal Hirte, Eric Winquist, Quincy Siu-Chung Chu, Christian Kollmannsberger, Ralph Wong, Thierry Alcindor et al. · 2024 · EClinicalMedicine
Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression
Nan Zhang, Zhou Haizhen, Runqi Zhang, Xiaoju Li · 2024 · Frontiers in Immunology
Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasis
Yucheng Fu, Qi Liu, Qiyuan Bao, Junxiang Wen, Zhuochao Liu, Yuehao Hu, Guoyu He, Cheng Peng, Yiqi Xu, Weibin Zhang · 2021 · Hereditas
The value of Ki-67 as a prognostic biomarker in osteosarcoma: A systematic review and meta-analysis
Yanqiang Chen, Jingsheng Liu, Bin Zhou, Mingxuan Yang, Haijun Feng · 2022 · Asian Journal of Surgery
LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients
Yong Bi-cheng, Jin-Chang Lu, Xian-Biao Xie, Qiao Su, Pingxian Tan, Qing-Lian Tang, Jing Wang, Gang Huang, Ju Han, Hongwen Xu et al. · 2017 · Tumor Biology
Allogenic γδ T cell and tumor cell fused vaccine for enhanced immunotherapeutic efficacy of osteosarcoma
Yitian Wang, Jian Zhu, Wei Yu, Junjie Wang, Kaishun Xia, Chengzhen Liang, Huimin Tao · 2018 · Journal of bone oncology
Decreased long non‐coding RNA lincFOXF1 indicates poor progression and promotes cell migration and metastasis in osteosarcoma
Shengquan Yang, Jian Chen, Bin Lv, Jun Zhang, Deli Li, Mengyuan Huang, Yuan Li, Guoyong Yin · 2020 · Journal of Cellular and Molecular Medicine
Resistance of osteosarcoma cells to the proapoptotic effects of carfilzomib involves activation of mitogen activated protein kinase pathways
Lei Li, Yuchen Zhang, Jian Qiang, Lei Lei, Nan Lv, Ramone A. Williamson, Ping Chen, Dan Zhang, Jinsong Hu · 2020 · Experimental Physiology
Improving Bioavailability of Hydrophobic Prodrugs through Supramolecular Nanocarriers Based on Recombinant Proteins for Osteosarcoma Treatment
Shidong Wang, Bo Li, Hongliang Zhang, Jiayin Chen, Xin Sun, Jie Hua Xu, Tingting Ren, Yuanyuan Zhang, Chao Ma, Wei Guo et al. · 2021 · Angewandte Chemie
Identification of Epigenetic-Dysregulated lncRNAs Signature in Osteosarcoma by Multi-Omics Data Analysis
Junchao Huang, Jingwei Zhang, Haijun Xiao · 2022 · Frontiers in Medicine
Hypermethylated PODN represses the progression of osteosarcoma by inactivating the TGF-β/Smad2/3 pathway
Xiuxin Han, Yan Zhang, Feng Lu, Jinyan Feng, Chao Zhang, Guowen Wang · 2022 · Pathology - Research and Practice
Esterase-triggered rapid release of succinic anhydride conjugated curcumin co-prodrug for osteosarcoma therapy
Yuxin Wan, Zhenze Xie, Mingjie Wang, Yuelian Liu, Mubin Zheng, Dong Xu, Chang Du · 2023 · European Polymer Journal
Chondromodulin-I suppresses tumorigenesis of human osteosarcoma cells
Xiangbo Lin, Lijun Wang, Faming Wang · 2017 · Molecular Medicine Reports
Current status of proteomics of soft tissue sarcomas
Tadashi Kondo · 2017 · Expert Review of Proteomics
Phosphoinositide-specific phospholipase C isoforms are conveyed by osteosarcoma-derived extracellular vesicles
Enrica Urciuoli, Martina Leopizzi, Valeria Di Maio, Stefania Petrini, Valentina Doria, Ezio Giorda, Marco Scarsella, Carlo Della Rocca, Vincenza Rita Lo Vasco, Barbara Peruzzi · 2020 · Journal of Cell Communication and Signaling
Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma
Junfeng Chen, Xiaojun Guo, Guangjun Zeng, Jianhua Liu, Bin Zhao · 2020 · Computational and Mathematical Methods in Medicine
A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients
Bo Wu, Zhan Wang, Nong Lin, Xiaobo Yan, Zhangchun Lv, Zhimin Ying, Zhaoming Ye · 2021 · Medicine
The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma
Guang‐Xian Zhong, Yunqing Wang, Hongxiang Wei, Meifang Chen, Huangfeng Lin, Zhen Huang, Jinlong Huang, Shenglin Wang, Jianhua Lin · 2021 · International Journal of General Medicine
Association of Preoperative Plasma D-Dimer and Fibrinogen and Osteosarcoma Outcome
Yanchuan Pu, Jin Wang, Jian‐Shu Wang, Shizhong Wang · 2022 · Frontiers in Oncology
Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63
Hu‐Cheng Liu, Jin Zeng, Bin Zhang, Xu‐qiang Liu, Min Dai · 2018 · Journal of Cellular Physiology
Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement
Melissa Divya Mathias, Alexander J. Chou, Paul A. Meyers, Neerav Narendra Shukla, Meera Hameed, Narasimhan P. Agaram, Lu Wang, Michael F. Berger, Michael Francis Walsh, Alex Kentsis · 2016 · Journal of Pediatric Hematology/Oncology
Osteosarcoma immunometabolism: emerging mechanisms and clinical implications
Bowen Tan, Jingyuan Ning · 2025 · Frontiers in Immunology
Two novel predictive biomarkers for osteosarcoma and glycolysis pathways: A profiling study on HS2ST1 and SDC3
Guozhi Yang, Jie Jiang, Ruifeng Yin, Zhian Li, Lei Li, Feng Gao, Chong Liu, Xinli Zhan · 2022 · Medicine
p53 Deficiency-Dependent Oncogenicity of Runx3
Kosei Ito, Shohei Otani, Yuki Date · 2023 · Cells
RNA-seq and Single-Cell Transcriptome Analyses of TRAIL Receptors Gene Expression in Human Osteosarcoma Cells and Tissues
Wenyu Feng, Haiyingjie Lin, Emel Rothzerg, Dezhi Song, Wenxiang Zhao, Tingting Ning, Qingjun Wei, Jinmin Zhao, David Wood, Yun Liu et al. · 2023 · Cancer Informatics
Exploring the Impact of Exosomal Cargos on Osteosarcoma Progression: Insights into Therapeutic Potential
Claire C. Chen, Claudia A. Benavente · 2024 · International Journal of Molecular Sciences
In silico and In vitro Evaluation of Cytotoxic Potential of Hinokitiol against Osteosarcoma by targeting Glycogen Synthase Kinase 3β
Binoy Varghese Cheriyan, Punithavel Srinivasan, George J Push, Karthik K Karunakar, Prasanna Bharathi Sainath, Shanmugam Anandakumar, Anitha Roy, Karthikeyan Elumalai · 2024 · Turkish Journal of Pharmaceutical Sciences
Ziyuglycoside II, a triterpene glycoside compound in Sanguisorbae officinalis l. extract, suppresses metastasis in osteosarcoma via CBX4-mediated Wnt/β-catenin signal pathway
Zhewen Deng, Jitong Yuan, Beiting Ma, Jie Zhu, Bingrong Yan, Jingxun Wei, Xin Jin, Jiaqi Li, Qi Zhang, Bo Ma · 2024 · Phytomedicine
Exosomal mRNA Cargo are biomarkers of tumor and immune cell populations in pediatric osteosarcoma
Jonathan Lian K Ong, Nur Fatimah Farzanah Jalaludin, Meng Kang Wong, Sheng Hui Tan, Clara Angelina, Sarvesh Abhay Sukhatme, Trifanny Yeo, Chwee Teck Lim, York Tien Lee, Shui Yen Soh et al. · 2024 · Translational Oncology
The combination of apatinib and antigen-specific DC-induced T cells exert antitumor effects by potently improving the immune microenvironment of osteosarcoma
Tu Hu, Wei Sun, Yongjia Jin, Yan Dong, Wanlin Liu, Zhengwang Sun, Yang Xiang, Yong Chen · 2024 · Heliyon
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma
Satoshi Takagi, Mikako Nakajima, Sumie Koike, Miho Takami, Yoshiya Sugiura, Seiji Sakata, Satoko Baba, Ai Takemoto, Tianyi Huang, Yosuke Seto et al. · 2024 · Oncogene
Transketolase promotes osteosarcoma progression through the YY1 ‐ PAK4 axis
Doudou Jing, Wei Wu, Xin Huang, Zhenhao Zhang, Xuanzuo Chen, Fuhua Huang, Jian‐Xiang Liu, Zhicai Zhang, Zengwu Shao, Feifei Pu · 2025 · FEBS Journal
Bone Metastasis Mediates Poor Prognosis in Early‐Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation
Shi Yin, Xiaohui Zhai, Yaoying Li, Ruixin Zeng, Di Zhang, Xiaoqing Sun, Ziying Zhang, Huashe Wang, Caiqin Wang · 2025 · Cancer Medicine
Integrative single-cell and bulk RNA-seq analysis identifies lactylation-related signature in osteosarcoma
Xie Zhou, Xiao Qu, Jun Zhang, Yanran Huang, Zhao Runhan, Dagang Tang, Ningdao Li, Zhule Wang, Xiaoji Luo · 2025 · Functional & Integrative Genomics
Identification of Nogo-B as a potential therapeutic target of osteosarcoma via stereochemically selective covalent probes
Jian Xue, Meng Li, Kang Li, Meiting Wang, Jiabin Yin, Donghui Sun, Yaqi Deng, Qinghua Wei, Jiemin Wong, Tong Zhu et al. · 2025 · Cell Death and Disease
CAFs exosomal miR-21-5p suppresses ferroptosis and promotes proliferation and migration in osteosarcoma
Xiaoying Niu, Wen Tian, Yuanmeng Ke, Yifan Li, Xinxin Zhang · 2025 · Cancer Cell International
Update of Key Clinical, Histological and Molecular Features of Malignant Bone Tumours Arising in the Craniofacial Skeleton
Simon Haefliger, Vanghelita Andrei, Daniel Baumhoer · 2022 · Frontiers in Oncology
IRF2 Destabilizes Oncogenic KPNA2 to Modulate the Development of Osteosarcoma
Shuchi Xia, Yiqun Ma · 2022 · Journal of Oncology
MiR-125b-5p/STAT3 Axis Regulates Drug Resistance in Osteosarcoma Cells by Acting on ABC Transporters
Yang� Yang, Yueyuan Chen, Jiajia Liu, Bo Zhang, Linlin Yang, Jianhua Xue, Zexu Zhang, Lili Qin, Rongpeng Bian · 2023 · Stem Cells International · Retracted
TAF1D Functions as a Novel Biomarker in Osteosarcoma
Yu-Nan Man, Yu Ling Sun, Peijun Chen, Hao Wu, Maolin He · 2023 · Journal of Cancer
Circadian rhythm-associated lncRNA RP11-414H17.5 as a key therapeutic target in osteosarcoma affects the tumor immune microenvironment and enhances malignancy
Liangkun Huang, Wanting Liang, Wenxiang Cai, Hao Peng · 2023 · Journal of Orthopaedic Surgery and Research
Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF
Sjahjenny Mustokoweni, Ferdiansyah Mahyudin, Rosy Setiawati, Dian Nugrahenny, Mohamad Hidayat, Handono Kalim, Karyono Mintaroem, Loeki Enggar Fitri, Pancras C.W. Hogendoorn · 2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Bibliometric analysis and visualisation of research hotspots and frontiers on omics in osteosarcoma
Xinyu Wang, Xin Cao, Zhongshang Dai, Zhehao Dai · 2024 · Journal of Cancer Research and Clinical Oncology
Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes
Ankush Sharma, Enrico Capobianco · 2017 · Cancer Informatics
Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression
Konghe Hu, Wen-Quan Xie, Songjia Ni, Shumin Yan, Gaoqiang Tian, Weizhong Qi, Yang Duan · 2020 · Oncology Reports
The role of significantly deregulated MicroRNAs in osteosarcoma based on bioinformatic analysis
Junwei Liu, Siyu Wu, Xiaoyu Xie, Ziming Wang, Qianqian Lei · 2020 · Technology and Health Care
MicroRNA‑1226‑3p has a tumor‑promoting role in osteosarcoma
Yong Li, Dai Song, Ting An, Jie Liu, Qian Yang, Shaokui Nan · 2021 · Oncology Letters
Construction and Validation of an Autophagy-Related Prognostic Model for Osteosarcoma Patients
Qian Hu, Ting Lei, Pengfei Lei, Yihe Hu · 2021 · Journal of Oncology
Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma
Jun Wang, Mingzhi Gong, Zhenggang Xiong, Yangyang Zhao, Deguo Xing · 2021 · Journal of Orthopaedic Surgery and Research
UHRF1 associated with osteogenic differentiation of MSCs contributes to osteosarcoma progression and has clinical prognostic impact in osteosarcoma
Zimo Zhou, Da Liu, Sen Qin, Senxiang Chen · 2021 · Critical Reviews in Eukaryotic Gene Expression
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment
Régis Brion, Malika Gantier, Kévin Biteau, Julien Taurelle, Bénédicte Brounais-Le Royer, Franck Verrecchia, Françoise Rédiní, Romain Guiho · 2022 · Cancers
Primary breast osteosarcoma in a patient previously treated for ipsilateral invasive ductal carcinoma: An unusual case report with clinical and genomic features
Siji Zhu, Haoyu Wang, Lin Lin, Xiaochun Fei, Jiayi Wu · 2023 · Frontiers in Oncology
LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
Jiayu Li, Xuhui Yuan, Cong Ma, Junhong Li, Gaoyang Qu, Bo Yu, Feng Cai, Yuanxiang Peng, Lang Liu, Duo Zeng et al. · 2023 · Frontiers in Oncology
Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma
Chengfeng Yi, Zijun Li, Qingzhong Zhao, Deliang Gong, Shibing Zhao, Zhigang Chen, Cheng Chen, Erbao Bian, Dasheng Tian · 2023 · Biochemical Genetics
MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells
Clément Veys, Flavie Boulouard, Abderrahim Benmoussa, Manon Jammes, Émilie Brotin, Françoise Rédiní, Laurent Poulain, Nicolas Gruchy, Christophe Denoyelle, Florence Legendre et al. · 2023 · Frontiers in Oncology
A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma
Jie Shao, Yi Zhang, Zhu Chang, Shiyao Du, Wei Li, Yushu Bai, Chunwen Lu, Tianming Xu · 2023 · Acta Biochimica et Biophysica Sinica
Construction and validation of a prognostic model for osteosarcoma patients based on autophagy-related genes
Biao Ning, Yixin Liu, Tianzi Xu, Yi Li, Dongyi Wei, Tianhe Huang, Yongchang Wei · 2022 · Discover Oncology
Targeting RNA Polymerase I Transcription Activity in Osteosarcoma: Pre-Clinical Molecular and Animal Treatment Studies
Chang-Won Kang, Anneke C. Blackburn, Amos Hong Pheng Loh, Kuick Chik Hong, Jian Yuan Goh, Nadine Hein, Denis Drygin, Christopher Richard Parish, Ross D. Hannan, Katherine M. Hannan et al. · 2023 · Biomedicines
A two‐stage drop‐the‐losers design for time‐to‐event outcome using a historical control arm
Rachid Abbas, James M. S. Wason, Stefan Michiels, Gwénaël Le Teuff · 2021 · Pharmaceutical Statistics